This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open-label phase IIIb study of regorafenib in p...
Clinical trial

An open-label phase IIIb study of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed after standard therapy

Read time: 1 mins
Last updated:29th Mar 2012
To provide regorafenib to subjects diagnosed with metastatic colorectal cancer who have failed all approved standard therapies and to assess the safety of regorafenib
Category Value
Study start date 2012-03-29

View full details